Mattia Altini

1.3k total citations
67 papers, 748 citations indexed

About

Mattia Altini is a scholar working on Oncology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Mattia Altini has authored 67 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Economics and Econometrics and 13 papers in Epidemiology. Recurrent topics in Mattia Altini's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (10 papers) and COVID-19 and healthcare impacts (9 papers). Mattia Altini is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (10 papers) and COVID-19 and healthcare impacts (9 papers). Mattia Altini collaborates with scholars based in Italy, United States and South Africa. Mattia Altini's co-authors include J J Rippey, Oriana Nanni, Ilaria Massa, Carla Masini, Maria Pia Fantini, Dino Amadori, Chiara Reno, Americo Cicchetti, Paola Rucci and Francesca Bravi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Mattia Altini

62 papers receiving 728 citations

Peers

Mattia Altini
Fiona L. Dignan United Kingdom
Carolyn E. Behrendt United States
Barbara H. Johnson United States
Roos Colman Belgium
Thomas V. Jones United States
Mattia Altini
Citations per year, relative to Mattia Altini Mattia Altini (= 1×) peers Dahlia Weitzman

Countries citing papers authored by Mattia Altini

Since Specialization
Citations

This map shows the geographic impact of Mattia Altini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mattia Altini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mattia Altini more than expected).

Fields of papers citing papers by Mattia Altini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mattia Altini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mattia Altini. The network helps show where Mattia Altini may publish in the future.

Co-authorship network of co-authors of Mattia Altini

This figure shows the co-authorship network connecting the top 25 collaborators of Mattia Altini. A scholar is included among the top collaborators of Mattia Altini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mattia Altini. Mattia Altini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altini, Mattia, Gianni Amunni, Ovidio Brignoli, et al.. (2025). Real World Evidence in Oncology: An Italian examples-based Expert Opinion on Advancing Clinical and Regulatory Decision-Making. 5(1). 7–7. 1 indexed citations
2.
Bolcato, Matteo, et al.. (2023). Aspetti medico-legali e organizzativi nell’era del Patient blood management. Recenti Progressi in Medicina. 114(12). 730–734. 1 indexed citations
3.
Krulichová, Iva Selke, Gisbert Selke, Marion Bennie, et al.. (2022). Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study. Pharmacoepidemiology and Drug Safety. 31(10). 1046–1055. 26 indexed citations
4.
Paolucci, Matteo, Michele Romoli, Mattia Altini, et al.. (2022). Drip-and-ship toward mothership model for mechanical thrombectomy during COVID-19 pandemic: a retrospective analysis. Neurological Sciences. 44(1). 1–7. 2 indexed citations
5.
Massa, Ilaria, Flavia Foca, Angelo Delmonte, et al.. (2022). Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer. Cancers. 14(18). 4481–4481. 4 indexed citations
6.
Casula, Manuela, Federica Galimberti, Marica Iommi, et al.. (2022). Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies. International Journal of Environmental Research and Public Health. 19(19). 12101–12101. 5 indexed citations
7.
Maltoni, Roberta, Tania Rossi, Francesco� Fabbri, et al.. (2022). Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Current Oncology. 29(2). 433–438. 1 indexed citations
8.
Roncadori, Andrea, Ilaria Massa, Oriana Nanni, et al.. (2021). How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers?. Human Vaccines & Immunotherapeutics. 18(1). 1978795–1978795. 18 indexed citations
9.
Passardi, Alessandro, Patrizia Serra, Caterina Donati, et al.. (2021). An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study. Journal of Medical Internet Research. 23(12). e31321–e31321. 1 indexed citations
10.
Messina, Rossella, Marica Iommi, Paola Rucci, et al.. (2021). Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study. Acta Diabetologica. 59(1). 95–104. 19 indexed citations
12.
Mancini, Silvia, Lauro Bucchi, Orietta Giuliani, et al.. (2020). Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme. Digestive and Liver Disease. 52(4). 452–456. 8 indexed citations
13.
Cerchione, Claudio, Giovanni Martinelli, Marco Picardi, et al.. (2020). Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. Journal of Clinical Medicine. 9(2). 395–395. 6 indexed citations
14.
Altini, Mattia, et al.. (2020). Mitigating strategies and nursing response for cancer care management during the COVID‐19 pandemic: an Italian experience. International Nursing Review. 67(4). 543–553. 16 indexed citations
15.
Paganelli, Giovanni, Maddalena Sansovini, Silvia Nicolini, et al.. (2020). 177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 152–160. 24 indexed citations
16.
Altini, Mattia, Gerardo Musuraca, Roberta Maltoni, et al.. (2020). The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology. Expert Review of Pharmacoeconomics & Outcomes Research. 21(3). 503–509. 11 indexed citations
17.
Altini, Mattia, Roberta Maltoni, Fabio Falcini, et al.. (2019). Key performance indicators for monitoring the integrated care pathway in breast cancer: the E.Pic.A. project. SHILAP Revista de lepidopterología. 5(1). 31–38. 2 indexed citations
18.
Amadori, Dino, Patrizia Serra, Lauro Bucchi, et al.. (2016). The Mwanza Cancer Project. The Lancet Oncology. 17(2). 146–148. 22 indexed citations
19.
Bravi, Francesca, Elisa Carretta, Simona Calugi, et al.. (2015). L’esperienza di cura di pazienti con neoplasia al colon retto e mammella in follow-up. L’indagine esplorativa nella Rete Oncologica di Area Vasta Romagna. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 16(2). 131–138. 1 indexed citations
20.
Rippey, J J, et al.. (1982). Prediction of aggressive behavior in basal cell carcinoma. Cancer. 49(3). 533–537. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026